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Abstract 
A library of polymer-coated gold nanoparticles (AuNPs) differing in size and surface 
modifications was examined for uptake and induction of cellular stress responses in 
the endoplasmic reticulum (ER stress) in human brain endothelial cells (hCMEC/D3). 
ER stress is known to affect the physiology of endothelial cells (ECs) and may lead 
to inflammation or apoptosis. Thus, even if applied at non-cytotoxic concentrations 
ER stress caused by nanoparticles should be prevented to reduce the risk of 
vascular diseases and negative effects on the integrity of barriers (e.g. blood-brain 
barrier). We exposed hCMEC/D3 to twelve different AuNPs (three sizes: 18, 35, and 
65 nm, four surface-modifications) for various times and evaluated their effects on 
cytotoxicity, proinflammatory mediators, barrier functions and factors involved in ER 
stress. We demonstrated a time-dependent uptake of all AuNPs and no cytotoxicity 
for up to 72h of exposure. Exposure to certain AuNPs resulted in a time-dependent 
increase in the proinflammatory markers IL-8, MCP-1, sVCAM, sICAM. However, 
none of the AuNPs induced an increase in expression of the chaperones and stress 
sensor proteins BiP and GRP94, respectively, or the transcription factors ATF4 and 
ATF6. Furthermore, no upregulation of the UPR stress sensor receptor PERK, no 
active splicing product of the transcription factor XBP1 and no upregulation of the 
transcription factor CHOP were detectable. In conclusion, the results of the present 
study indicate that effects of different-sized gold nanoparticles modified with various 
polymers were not related to the induction of ER stress in brain microvascular 
endothelial cells or led to apoptosis. 
 
Abbreviations 
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IRE1a: inositol-requiring enzyme 1 a, UPR unfolded protein response, BiP: 
immunoglobulin heavy-chain-binding protein, xbp1: X-box binding protein 1, PERK: 
protein kinase RNA-like ER kinase, ATF: activating transcription factor, CHOP: 
CCAAT-enhancer-binding protein homologous protein, GRP94: glucose-regulated 
protein 94, ZO-1: zonula occludens-1. 
 
Introduction 
Detailed studies of the interactions of nanoparticles with healthy cells in vitro are 
necessary to ensure nanoparticle safety, especially if nanoparticles are targeted for 
use in biomedical applications such as radiation therapy, imaging (contrast agents), 
and regenerative medicine or as drug delivery systems. Gold nanoparticles (AuNPs) 
are chemically inert and have been shown to be biocompatible if the nanoparticles 
are not ultrasmall or do not contain stabilizing agents such as 
cetyltrimethylammonium bromide (CTAB) or citrate (Connor et al. 2005; Uboldi et al. 
2009; Freese et al. 2012b; Pan et al. 2007). However, there is still a need to examine 
each newly synthesized particle to exclude toxicity due to the absence of sufficient 
data to permit the classification of nanoparticles as ‘toxic’ or ‘non-toxic’, based solely 
on their physico-chemical characteristics. Even if AuNPs do not affect cell viability, 
nanoparticles have been shown to induce various cellular responses, including the 
secretion of proinflammatory mediators in dendritic cells (Villiers et al. 2010), or 
reactive oxygen species (ROS) production in brain tissue and liver of mice 
(Shrivastava et al. 2014). 
Surface modification with polymers can decrease the toxic effects of AuNPs (Alkilany 
A. M. et al. 2009). In addition, the modification of surfaces of AuNPs with various 
polymers can change their uptake properties in human dermal microvascular 
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endothelial cells (Freese et al. 2012a) and influence the amount of AuNPs that are 
internalized by endothelial cells from different locations of the body. Therefore, it may 
be possible to regulate targeting of AuNPs based on surface modifications and size 
(Freese et al. 2013). 
The interaction of AuNPs with brain microvascular endothelial cells is of great 
interest, since brain endothelial cells form a complex and tight barrier between the 
blood and brain tissue, the blood-brain barrier (BBB). Any impact on brain 
endothelial cells that consequently leads to a disruption of the BBB will influence 
endothelial cell ability to protect the brain from toxic substances. One of the cellular 
mechanisms that may impact the integrity of endothelial cells is ER stress. ER stress 
may be responsible for a decreased expression of tight junction proteins in primary 
human retinal endothelial cells which has been shown to result in increased 
permeability (Adachi et al. 2012). 
In general, ER stress is known to affect the function of endothelial cells and is 
characterized by the accumulation of unfolded and misfolded proteins in the 
endoplasmic reticulum. This leads to an activation of an ER stress signaling 
pathway, called the Unfolded Protein Response (UPR) which counteracts the stress 
situation. The first response of the cell is the re-establishment of homeostasis 
(Walter und Ron 2011; Ron und Walter 2007) by up-regulation of chaperone 
expression such as BiP and GRP94 (Schröder und Kaufman 2005). On the other 
hand, prolonged ER stress and ongoing activation of the UPR initiate apoptosis of 
cells (Tabas und Ron 2011). In addition, UPR plays a central role in many diseases 
such as diabetes and cancer (Walter und Ron 2011; Lin et al. 2008; Li et al. 2011) 
and a key role in various brain-related disorders such as Alzheimer’s disease, 
Parkinson's disease and cerebral ischemia 
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Xin et al. 2014; Roussel et al. 2013; Reinhardt et al. 2014). Since endothelial cells 
play a central role in the homeostasis of tissues and organs, the healing processes 
and the maintenance of barriers (brain, eye, testis), it is essential that ER stress in 
endothelial cells caused by nanoparticles, especially those that are being considered 
for medical applications is prevented. 
Initial studies have shown that the treatment of primary endothelial cells with silica 
nanoparticles can result in the induction of ER stress (Tsai et al. 2011; Christen und 
Fent 2012). In addition, AuNPs have been shown to lead to ER stress in human 
chronic myelogenous leukemia cells (Tsai et al. 2011). To the best of our knowledge, 
the effect of AuNPs in inducing ER stress has not been systematically investigated in 
endothelial cells. Thus, we have examined a library of 12 polymer-modified AuNPs 
with different sizes (18, 35, 65 nm), for their uptake in cultured human brain 
endothelial cells (hCMEC/D3), evaluated their cytotoxic activity and examined their 
effects on the expression of proinflammatory mediators and tight junction proteins. In 
addition, different ER stress-related factors were examined to determine if there 
were correlations with uptake and internalization, toxicity, proinflammatory marker 
expression or membrane integrity. 
 
Methods 
Gold nanoparticles 
The gold nanoparticles were synthesized and characterized as previously described. 
In addition to that also the role of solution conditions on nanoparticle aggregation 
was discussed (Gibson et al. 2011; Freese et al. 2012a). Importantly, we 
demonstrated that in the ECBM MV cell culture medium (PromoCell) supplemented 
with 15 % fetal calf serum, all of the nanoparticles were well dispersed. The AuNPs 
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studied had sizes of 18 nm, 35 nm and 65 nm and were modified with different 
polymers (glucosamine, hydroxypropylamine, taurine, (poly)ethylenglycol) as 
described previously (Gibson et al. 2009; Gibson et al. 2011; Freese et al. 2013). 
Cell culture 
The immortalized human cerebral microvascular endothelial cell line, hCMEC/D3 
was provided by Pierre-Olivier Couraud (Department of Cell Biology, Institute 
Cochin, Paris, France) and characterized as described previously (Weksler et al. 
2005). hCMEC/D3 were maintained on fibronectin-coated culture dishes in ECBM 
MV cell culture medium (PromoCell) supplemented with 15 % fetal calf serum, 
2.5 ng / mL basal fibroblast growth factor, 10 µg / mL sodium heparin (all Sigma-
Aldrich), penicillin (100 U/mL) and streptomycin (100 µg/mL) (Gibco). The cells were 
sub-cultivated twice a week. 
 
Nanoparticle treatment and microscopy 
For uptake studies cells were seeded onto fibronectin-coated LabTek chamber slides 
(Nunc) and treated with 100 µg / mL gold nanoparticles for 24 hours. Afterwards, 
cells were washed and fixed in 3.7 % paraformaldehyde for 15 minutes. After 
permeabilization with 0.2% TritonX-100, cells were stained first with mouse anti-
human CD31 antibody (DakoCytomation) and then the corresponding secondary 
antibody (goat anti-mouse Alexa Fluor 546; Molecular Probes) at room temperature 
for 1 hour each. Nuclei were counterstained with Hoechst 33342 dye (Sigma-
Aldrich). The LabTek chamber slides were embedded with GelMount (Biomeda) and 
analyzed via light/fluorescence microscopy (Olympus IX71 with Delta Vision system, 
Applied Precision, USA). 
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For analysing the uptake of AuNPs by transmission electron microscopy cells were 
seeded onto fibronectin-coated Thermanox coverslips (Nunc, Roskilde, Denmark), 
treated with 18 nm-sized Au-NPs (10 µg / mL) as described above and then fixed 
with cacodylate-buffered glutaraldehyde (Serva) (pH 7.2) for 20 minutes. This was 
followed by a fixation step in 1% (w/v) osmium tetroxide for 2 hours and dehydration 
in ethanol. Cells were transferred through propylene oxide. Afterwards the samples 
were embedded in agar-100 resin (PLANO, Germany) and polymerized at 60°C for 
48 hours. Ultrathin sections were cut with an ultramicrotome (Leica Microsystems, 
Germany), placed onto copper grids and stained with 1% (w/v) uranyl acetate in 
alcoholic solution and lead citrate. Ultrastructural analysis was performed with a 
transmission electron microscope, EM 410 (Philips; Eindhoven, Netherlands). 
Cell viability assessment 
Cells were seeded on 96-well plates (coated with fibronectin) and incubated with 
various concentrations of nanoparticles. Cells were then washed and cell viability 
was determined using the CellTiter 96 AQueous non-radioactive assay (Promega) as 
recommended by the manufacturer. 
 
Quantification of internalized gold nanoparticles by ICP-AES 
Internalized gold nanoparticles were quantified as described previously (Freese et al. 
2012a). Briefly, after reaching confluence cells cultured on fibronectin-coated 24-well 
plates were exposed to AuNPs (10 µg / mL). After 24 hours of treatment cells were 
washed, detached by trypsin/EDTA (Gibco) solution and transferred after the 
addition of 0.9 mL PBS to tubes. 0.15 mL of aqua regia was added and incubated 
overnight. Samples were then further diluted to 5mL using MilliQ water to give a total 
sample volume of 5 mL. These samples were then analyzed (3X) for total gold 
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content by inductively coupled plasma atomic emission spectroscopy (ICP-AES) and 
concentrations were determined using a gold standard (Fluka Analytical). The 
concentration of solubilized gold and the mass of the NPs was used to calculate the 
number of particles. The cell number of each well was used to determine the number 
of particles per cell. 
Determination of ER stress mediators 
Treatment and cell harvesting 
hCMEC/D3 were cultured on 48-well plates (TPP) until confluent and subsequently 
treated with various concentrations of nanoparticles. As a positive control for ER 
stress hCMEC/D3 were incubated with 2 µg / mL tunicamycin (Sigma) for 24 hours. 
After treatment and washing, cells from 3 wells were combined in RLT buffer and 1% 
mercapthoethanol (Qiagen) and stored at -80°C until RNA isolation. 
 
RNA-isolation and cDNA synthesis 
RNA was isolated using the RNeasy Midi Kit (Qiagen) as described by the 
manufacturer. The amount of RNA in each sample was measured with the 
NanoDrop ND1000 spectrophotometer. 300-500 ng RNA were used for the reverse 
transcription polymerase chain reaction according to a standard protocol using 
Omniscript RT kit (Qiagen), random primers (Microsynth) and RNase inhibitor 
(Promega GmbH). 
 
Real-time PCR 
For quantitative real-time PCR 3.75 ng cDNA were amplified using 12.5 μl of 
QuantiTectTM SYBR® Green PCR Master Mix and 100 nM of each primer per 
reaction. Quantitative real-time PCR was performed in triplicate with the 7300 Real-
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time PCR System (Applied Biosystems) using the following cycler program: 95°C, 15 
min; denaturation step: 94°C; 15 s; annealing step: 60°C 30 s; elongation step: 72°C 
35 s; dissociation: 95°C 15 s; 60°C 1 min; 95°C 15 s, and 40 cycles were performed 
in total. Ribosomal protein L13a (RPL13A) was used as an endogenous control to 
calculate ∆∆Ct. The following primers were used: 
 
Table 1 
 
Polymerase chain reaction 
10 ng cDNA were amplified by polymerase chain reaction (PCR) with specific primer 
pairs (1 µM each), and a master mix containing 14.875 µl RNAse-free water, 2.5 µl 
10-fold buffer, 0.5 µl 2' deoxyribonucleotides (dNTP) mix, and 0.125 µl Taq DNA 
polymerase (all Qiagen). PCR was performed using PCR System 9700 cycler 
(Applied Biosystems), 35 cycles and the following cycler program: 94°C, 2 min; 
94°C, 0.5 min; 60°C, 0.5 min; 72°C, 0.5 min; 72°C, 10 min. PCR products were 
separated by gel electrophoresis in a 3 % agarose gel including 0.02 % ethidium 
bromide and 1 % Tris/Borate/EDTA buffer. The primers used have been synthesized 
by Microsynth: 
Xbp1 u/s: for: 5’-CTGGAACAGCAAGTGGTAGA-3’, rev: 5’-
CTGGGTCCTTCTGGGTAGAC-3’ (Shang 2005). 
 
Enzyme-linked immunosorbent assay (ELISA) 
After exposure to the nanoparticles the supernatants of the cells were diluted in the 
appropriate assay diluent and analyzed via ELISA (DuoSet, R&D Systems) for 
secreted soluble proinflammatory mediators as recommended by the manufacturer. 
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Data analysis 
All experiments were done in triplicate and repeated as indicated. Data were 
analyzed with GraphPad Prism version 5.04 (GraphPad Software, San Diego 
California USA, www.graphpad.com). 
Results 
The AuNP library consisting of nanoparticles with sizes of 18, 35 and 65 nm each 
sequentially modified with four different coatings (glucosamine, hydroxypropylamine, 
taurine, poly(ethylenglycol) were screened for their effects on human brain 
endothelial cells (hCMEC/D3). These coatings were chosen to provide a range of 
surface chemistries which also give stable particles. The glucosamine, 
hydroxypropylamine and poly(ethyleneglycol) units are all hydrophilic coatings, but 
present different surface functionalities – e..g the PEG unit is well know protein -
resistant, non-immunogenic polymer which cannot donate hydrogen bonds. 
However, the hydroxypropylamine and glucosamine can donate and accept 
hydrogen bonds, changing the interfacial properties. Glucosamine can also 
(potentially) engage with receptors and transporters on cell surfaces. The 
nanoparticles have been reported in a previous study using electron microscopy, 
light scattering and UV-Vis, confirming them to all be colloidal stable in the conditions 
employed.Biocompatibility was determined after exposure to different concentrations 
of the nanoparticles (10, 50, 100, 250 µg / mL) and at four different exposure times 
(4h, 24h, 48h, 72h). None of the AuNPs had any detectable effect on cell viability as 
determined by the measurement of the metabolic activity of the cells (see 
Supplementary Material Figure 1). In addition, the uptake behavior of the various 
AuNPs in hCMEC/D3 after 4 and 24 hours was examined. In Figure 1 A-D, 
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representative images of the internalization of 35 nm gold nanoparticles in brain 
endothelial cells are shown. The images demonstrate that depending on the 
modification of the AuNPs the nanoparticles were internalized in varying amounts. 
Light microscopy was used to identify agglomerates of internalized AuNPs. After 24 
hours the AuNPs were present in the perinuclear region of the cell and transmission 
electron microscopy confirmed the results seen by light microscopy (Figure 1 F - I). 
The detailed TEM images demonstrated that AuNPs were located in vesicles (Figure 
1 F’ – I’) but were neither freely dispersed in the cytoplasm, nor located in 
mitochondria or the cell nucleus. The amount of internalized AuNPs was quantified 
by inductively coupled plasma and atomic emission spectroscopy (ICP-AES). Briefly, 
after exposure and washing the cells (containing AuNPs) were digested with Aqua 
Regia and the total gold concentration determined. This was then converted to 
particles, using the TEM diameters of the gold particles, assuming a density of 19.3 
g.cm-3. This was then corrected to the cell density. This method enables us to rule 
out effects due to the higher volume (and hence gold atoms) of larger particles 
compared to smaller. The results presented in Figure 1 E show that all sizes of 
nanoparticles were internalized, but in different amounts. The 18 nm nanoparticles 
were internalized in a higher amount compared to the nanoparticles with a mean 
diameter of 35 nm or 65 nm. Interestingly, the uptake behavior of the 35 nm-sized 
hydroxypropylamine-coated AuNP was different from those of the nanoparticles with 
sizes of 18 nm or 65 nm highlighting the delicate balance between size and surface 
chemistry. 
Since AuNPs were internalized in various amounts by brain endothelial cells but did 
not cause any cytotoxic effect, physiological functions of brain endothelial cells were 
examined. Cells exposed to the various AuNPs were examined to evaluate changes 
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in the secretion pattern of proinflammatory mediators. Interestingly, a time-
dependent exposure effect on the secretion of inflammatory mediators could be 
observed for some but not all of the AuNPs. 4 hours of exposure to the AuNPs did 
not result in changes to the secretion of IL-8, MCP-1, sVCAM and sICAM (data not 
shown). However, after 24 hours all sizes of glucosamine-coated gold nanoparticles 
as well as the 35 nm hydroxypropylamine-coated nanoparticles showed an 
increased secretion of these cytokines compared to the untreated control (Figure 2). 
Moreover, a major increase in the secretion of the proinflammatory mediators was 
detected after increasing the incubation period to 48 and 72 hours. Decreasing the 
AuNP concentration lead to a decreased secretion of IL-8, IL-6 and MCP-1 (see 
Supplementary Material Figure 2). In summary, changes to the secretion pattern of 
proinflammatory mediators occurred with certain nanoparticles indicating that certain 
physico-chemical properties (surface modification and size) could have an impact on 
the physiology of brain endothelial cells while others did not. However, none of the 
nanoparticles induced levels of changes in proinflammatory mediator expression as 
achieved by the treatment of cells with the positive control, TNFα. 
In addition to the effects of modified AuNPs on cell viability, uptake and secretion of 
proinflammatory cytokines, a further physiological function of blood-brain barrier 
endothelial cells, namely the presence of tight junctions, was examined after 
exposure to the AuNPs. In Figure 3 the expression of tight junction proteins after 
treatment with AuNPs is shown. The expression of occludin and ZO-1 decreased in 
all treated cells although not significantly. However, a significant decrease in the 
expression of ZO-1 was observed on cells exposed to 65 nm hydroxypropylamine-
coated AuNPs. The expression of claudin-5 was less affected in cells exposed to the 
nanoparticles and the changes were not significant when compared to the control 
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cells. In summary, the expression of the tight junction proteins investigated 
decreased in varying amounts. A correlation of nanoparticle size or surface 
modification and a decrease in the expression of TJ proteins was not obvious. The 
larger sized NPs appeared to have a tendency towards changing tight junction 
protein expression, although a significant difference could not be detected. 
ER stress responses were examined to determine whether these were responsible 
for the altered expression of tight junction proteins and the induction of secretion of 
proinflammatory mediators after exposure to the nanoparticles. Cells exposed to 
various concentrations of AuNPs were analyzed for spliced XBP1 mRNA. Figure 4 
shows the results of cells examined for the spliced variant of XBP1 mRNA after 
treatment with AuNPs for 4 hours. In Figure 4A both the spliced and unspliced 
variant of XBP1 were detected. The spliced variant was observed at very low 
amounts even after an exposure to 150 µg / mL AuNPs, compared to the positive 
control, treated with tunicamycin (Figure 4 A’; Supplementary Material Figure 3 B). 
Real-time PCR was performed to detect the amount of spliced XBP1 in cells that 
were treated with 150 µg / mL AuNPs (Figure 4B). No changes in the splicing of 
XBP1 were observed, indicating no activation of UPR after 4 hours of AuNP 
exposure. In contrast, cells exposed to 18 nm AuNPs showed a decreased amount 
of spliced XBP1 mRNA. In addition, no increased amount of XBP1s was detected by 
real-time PCR in cells that were treated with AuNPs for 24 hours (see 
Supplementary Material Figure 3 A). 
The expression patterns of further UPR mediators were examined to investigate if 
these were responsible for the effect of various AuNPs on ER stress in hCMEC/D3. 
In Figure 5, the results demonstrated that the expression of the chaperones BiP and 
Grp94 was not altered after treatment with various AuNPs for 4 and 24 hours. In 
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contrast, the treatment with tunicamycin, the positive control for UPR activation, 
resulted in a 14.3-fold and 13.1-fold upregulation of BiP or Grp94, respectively. Even 
after a prolonged exposure to nanoparticles for up to 72h, the expression of BiP was 
not induced (see Supplementary Material Figure 4). In addition, the expression of the 
transcription factor ATF4, which regulates the gene expression of UPR target genes, 
was also not induced by treatment with AuNPs, compared to the treatment with 
tunicamycin. In contrast, the expression of ATF4 after exposure to the 65 nm AuNPs 
coated with glucosamine (65-gluc) or hydroxypropylamine (65-hyd) for 4 hours was 
slightly decreased (0.6-fold) compared to the untreated control. In addition, the 
expression patterns of the UPR factors, IRE1α, PERK and ATF6 were analyzed. No 
changes were observed in the expression of PERK and ATF6. However, IRE1α 
expression was slightly induced after 24 hours, although a short term exposure to 
the NPs did not lead to an upregulation. Differences in the upregulation after 24 
hours of exposure to the AuNPs were detectable. However, no correlation between 
the surface modification or size of the nanoparticles and the upregulation of IRE1α 
could be demonstrated. Finally, studies were performed to determine if the exposure 
of cells to AuNPs resulted in an induction of apoptosis. Nanoparticle-treated cells 
were examined for the induction of CHOP expression, an early mediator of ongoing 
apoptosis, after different exposure times. As shown in Figure 6, none of AuNPs 
tested induced a change in the expression of CHOP after 4 hours of treatment. Even 
after prolonged exposure (72 hours) the expression of CHOP did not change 
significantly, although a slight increase of CHOP expression after 72 hours could be 
shown for the medium-sized taurine-coated AuNPs (35-taurine; 1.7-fold). In 
summary, the AuNPs evaluated in these studies were biocompatible and non-toxic, 
the particles exhibited differences in their internalization by hCMEC/D3, and some of 
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the particles induced the expression of proinflammatory cytokines. However, none of 
the particles induced either the expression of prominent ER stress markers or led to 
an ongoing apoptosis. 
 
Discussion 
The use of AuNPs for biomedical applications is justified by their physico-chemical 
characteristics and biocompatibility, in particular when coated with certain polymers 
(Boisselier und Astruc 2009; Wilkins et al. 2015; Phillips et al. 2014). However, even 
if a direct toxicity of AuNPs is minimal, further studies have to be carried out prior to 
using these particles for medical applications to ensure that complex non-toxic 
interactions of nanoparticles with cells do not change other cellular functions. An 
intravenous application of NPs results in a direct interaction of the nanoparticles with 
endothelial cells (ECs) lining the inner wall of the vasculature. It is well-known that 
ECs play an important role in the maintenance of the homeostasis of tissues. 
Therefore, the physiological function of these cells after addition of a substance into 
the bloodstream needs to be preserved. ER stress and UPR are factors which have 
been shown to impact the function of ECs in various ways (e.g. wound healing 
processes (Tsaryk et al. 2015). Ongoing ER stress also leads to apoptosis of cells 
(Szegezdi et al. 2006), and thus it is essential to minimize the effects of 
nanoparticles which may lead to ER stress. 
Although non-toxic, the AuNPs examined in the study were internalized in varying 
amounts and thus one could speculate that different numbers of particles within a 
cell could affect the transport of proteins within the cell, resulting in a disturbance of 
normal cell functions and of protein transport in general. Relevant experiments 
showed an induction of proinflammatory cytokines and a decrease in the expression 
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of tight junction proteins with certain AuNPs on the brain endothelial cells. Thus, a 
slight modification of a NP can induce certain physiological changes in certain cells. 
ER stress responses as factors responsible for these phenomena were examined in 
detail in these studies. 
No cytotoxic effect of the AuNPs was observed on hCMEC/D3 after exposure times 
for up to 72 hours. These results agree with those observed for primary human 
dermal microvascular endothelial cells (HDMEC) previously described (Freese et al. 
2012a). In addition, a similar pattern of internalization of AuNPs was observed for the 
brain endothelial cells as for the HDMEC. However, a significant difference was 
observed in the uptake of 35 nm hydroxypropylamine-coated AuNPs in HDMEC and 
hCMEC/D3 (Freese et al. 2013). In the present study, it was shown that hCMEC/D3 
internalized the surface-modified AuNPs in various amounts. Our results agree with 
previous studies that have shown that PEGylated AuNPs were modestly internalized 
in various cell types, e.g. (Bouzas et al. 2014). Our microscopic studies confirmed 
that the internalized AuNPs were localized in the perinuclear region of the cells and 
were located in vesicles as typical for these sizes of nanoparticles, and that the 
nanoparticles were not freely distributed in the cytoplasm (Chou, Leo Y T et al. 
2011). Changes to the induction of proinflammatory mediators by the endothelial 
cells were examined after exposure to the various AuNPs. Although Zhang and co-
workers showed that 60 nm AuNPs did not cause the induction of proinflammatory 
mediators (IL-6, TNF-α) in macrophages (Zhang et al. 2010), the ELISA results 
presented in the present study demonstrated an induction of proinflammatory 
mediators in hCMEC/D3. In addition, differences in the induction pattern of 
proinflammatory mediators were observed and these were dependent on the coating 
of the AuNPs. Cells exposed to glucosamine-coated nanoparticles were specially 
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affected, as seen by induction of the secretion of IL-8, MCP-1, soluble (s)ICAM and 
sVCAM. These factors are known to be induced in endothelial cells in the presence 
of endotoxins or TNFα (Makó et al. 2010; Buttenschoen et al. 2010; Peters et al. 
2003). The AuNPs were shown to be free of endotoxin (data not shown) (Unger et al. 
2014), therefore, it appears that the induction of proinflammatory mediators is a 
characteristic factor of the coated AuNPs. While the induction of inflammatory 
cytokines was shown for the medium-sized hydroxypropylamine-coated AuNPs (65-
hyd), the effects induced by the glucosamine-coated AuNPs were not related to a 
particular size of the AuNPs. Considering the fact that various amounts of 
glucosamine-coated AuNPs of different sizes were internalized in hCMEC/D3, the 
induction of proinflammatory factors could not be attributed to the amount of 
nanoparticles taken up. Others have demonstrated that glucosamine itself can 
induce oxidative stress in primary human chondrocytes (Valvason et al. 2008), which 
thus might lead to the induction of inflammatory processes in endothelial cells. In 
contrast, other groups have shown that a direct effect of glucosamine on cells acted 
in an anti-inflammatory manner (Shea 2001). Nevertheless, in combination with 
AuNPs the induction of proinflammatory factors was significant compared to the 
untreated control. 
A unique characteristic of brain microvascular endothelial cells is the high expression 
of tight junction proteins. Brain endothelial cells are highly specialized endothelial 
cells that form the blood-brain barrier, which is a highly organized and regulated 
barrier preventing the paracellular transport of most substances from the blood to the 
brain and vice versa. Due to differences in the uptake amounts of the various AuNPs 
and the expression of proinflammatory mediators, the brain endothelial cells were 
examined for changes in the expression pattern of tight junction proteins after 
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exposure to the AuNPs. Trickler et al. demonstrated a mild change in the barrier 
function of porcine brain endothelial cells after exposure to several sizes of 
unmodified AuNPs (Trickler et al. 2011). The same was shown in a previous 
published study that focussed on the investigation of the transport properties of 
hydroxypropylamine-coated AuNPs across a BBB model system (Freese et al. 
2013). The decrease in the expression of tight junction proteins in hCMEC/D3 in the 
present study may be correlated with the induction of ER stress. Adachi et al. 
showed that primary human retinal endothelial cells exhibited a decreased 
expression of tight junction proteins as a consequence of increased ER stress 
(Adachi et al. 2012). Furthermore, they demonstrated that the reduction in the 
expression of tight junction proteins but also inflammation processes were linked to 
both oxidative stress and to ER stress. Changes in ER stress factors in hCMEC/D3 
were evaluated in the present study and the results indicated that prominent markers 
of ER stress such as BiP, ATF4 and ATF6 were not differentially expressed in brain 
endothelial cells after exposure to the polymer-modified AuNPs. This is in contrast to 
Tsai et al. who demonstrated an induction of ER stress mediators followed by 
cytotoxicity of AuNPs in leukemia K562 cells (Tsai et al. 2011). The only factor 
affected in hCMEC/D3 was IRE1α. IRE1α represents one of three prominent 
transmembrane receptors of UPR. In addition to IRE1α upregulation the ER stress 
mediators, BiP and ATF6 are upregulated in activated UPR (Shen et al. 2004). 
However, in our study none of the mediators were affected. In addition, splicing of 
XBP1 mRNA was not detected. This transcription factor has been shown to be one 
of the most prominent markers and mediators for activated UPR. This is in 
accordance with the result published by Khan and colleagues, who showed that 
18 nm citrate-stabilized AuNPs did not induce the splicing of XBP-1 mRNA in HeLa 
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cells (Khan et al. 2007). However, they did not systematically screen different sizes 
and surface modifications of AuNPs. Moreover, their study of ER stress was limited 
to the analysis of XBP1 splicing. Certainly, in combination with our studies in which 
all three prominent pathways of UPR were analyzed, it appears that an activation of 
UPR after exposure to this size of particles in different cell types can be excluded. 
Various polymer-modified AuNPs were analyzed by Hauck and colleagues for 
potential changes in the gene expression of HeLa cells with the focus on heat shock 
proteins (cell stress mediators). These studies used an expression array to 
determine the modulation of 10,000 genes after exposure of cells to polymer-
modified gold nanorods (Hauck et al. 2008). Surprisingly, only 35 genes were 
regulated after exposure to the gold nanorods. Most of the genes were involved in 
apoptosis or cell metabolic functions, but not cell stress factors. A comparison with 
our study is difficult on account of the different polymers used, the different shapes of 
the nanoparticles and the cancer cell line used by Hauck et al. Nevertheless, both 
studies demonstrate that cell stress mediators were not activated after treatment with 
polymer-coated AuNPs. Christen and colleagues focused their attention on the 
induction of ER stress in the human hepatoma cell line Huh7 after treatment with 
silica nanoparticles (SiNPs). They demonstrated an up-regulation of BiP and 
described splicing of XBP1 in these cells. Moreover, they showed that silver-coated 
SiNPs (SiO2–Ag-NPs)	 also induced BiP upregulation (Christen und Fent 2012). An 
activation of UPR in primary endothelial cells (HUVEC) and Chinese hamster ovary 
(CHO) cells after treatment with ZnO nanoparticles was also demonstrated by Chen 
and colleagues (Chen et al. 2014). However, the same study showed that CeO2 
nanoparticles did not activate UPR. This was also true for the treatment of brain 
endothelial cells with polymer-coated AuNPs utilized in our study. In summary, these 
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studies demonstrate that depending on nanoparticle and cell type a range of effects 
on ER stress factor expression may be observed and therefore ER stress may act as 
a potential risk factor after NP exposure. 
A final consequence of ER stress can be identified by the expression of the 
transcription factor CHOP and the induction of apoptosis. An analysis of CHOP 
expression in brain endothelial cells exposed to the different AuNPs demonstrated 
that apoptosis was not induced. Since ATF4, which is thought to be a dominant 
inducer of CHOP, was not upregulated the results in our studies are in agreement 
with those previously described (Harding et al. 2000). However, Tsai and colleagues 
showed a time-depending up-regulation of CHOP after exposure to non-coated 
AuNPs in leukemia cells, this being accompanied by a very rapid increase in 
caspase 3 expression (Tsai et al. 2011). However, both genes were again down-
regulated after at least 48 hours following exposure. An induction of CHOP 
expression was also observed by Chen et al. in HUVEC and CHO cells after 
exposure to ZnO nanoparticles (Chen et al. 2014). Thus, under certain conditions 
and with certain NPs, the detection of ER stress-related proteins may be useful for 
identifying early cellular responses to nanoparticle exposure. However, our study 
demonstrated that polymer-modified AuNPs did not induce ER stress in brain 
microvascular endothelial cells. 
 
Conclusion 
We investigated the effects of twelve different gold nanoparticles on human brain 
endothelial cells after four different incubation times. Although different amounts of 
gold nanoparticles were internalized by the endothelial cells the results of the 
present study indicated that none of the gold nanoparticles exhibited cytotoxic effects 
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or induced ER stress. Furthermore, high doses of AuNPs did not induce ER stress or 
apoptosis even after an exposure time of 72 hours. In conclusion, none of the twelve 
unique polymer-modified gold nanoparticles induced ER stress factors in brain 
microvascular endothelial cells, although an effect on the expression of tight junction 
proteins could not be excluded. 
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Tables with captions 
Table 1: Oligonucleotides used for real-time PCR. Oligonucleotides were 
synthesized by Microsynth AG (www.microsynth.ch). 
Primer forward reverse 
   ATF4 5’-CTGCCCGTCCCAAACCTTAC-3’ 5’-CTGCTCCGCCCTCTTCTTCT-3’ 
ATF6 5'-CAGAACCCCAGCCACTTTCT-3’ 5’-GGCTCCGGTGAAGAGAGACT-3’ 
BiP 5’-ACTATGAAGCCCGTCCAGAAAGT-3’ 5’-TCGAGCCACCAACAAGAACA-3’ 
CHOP 5’-CACCACTCTTGACCCTGCTTC-3’ 5’-GCTCTGGGAGGTGCTTGTGA-3’ 
claudin-5 5’-GCCCTTAACAGACGGAATGA-3’ 5`-CTGCCGATGGAGTAAAGACC-3’ 
Grp94 5’-CGCTTCGGTCAGGGTATCTTT-3’ 5’-CCTTTGCATCAGGGTCAATGT-3’ 
IRE1a 5’-CTGGAGCCTAGAGAAGCAGC-3’ 5’-TTCTCATGGCTCGGAGGAGA-3’ 
occludin 5’-ACTTCAGGCAGCCTCGTTAC-3’ 5’-CCTGATCCAGTCCTCCTCCA-3’ 
PERK 5’-CCTTGGTGTCATCCAGCCTT-3’ 5’-ATGCTTTCACGGTCTCGGTC-3’ 
RPL13A 5’-CCTGGAGGAGGAGAGGAAAGAGA-3’ 5’-TCCGTAGCCTCATGAGCTGTT-3’ 
Xbp1 spliced 5’-CAGGATTCTGGCGGATTGACTC-3‘ 5’-CTGGGGAAGGGCATTTCAAGAA-3’ 
ZO-1 5’-TGCCATTACACGGTCCTCTG-3’ 5’-GGTTCTGCCTCATCATTTCCTC-3’ 
 
Figures captions 
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Figure 1: Uptake of various gold nanoparticles by endothelial cells after 24 
hours of exposure. 
hCMEC/D3 were exposed to 100 µg / mL AuNPs for 24 hours. (A - D) Cells were 
fixed and membranes were stained with anti-CD31 antibody (red). Nuclei were 
stained with Hoechst dye (blue). Agglomerates of AuNPs were detected as black 
dots (optical/fluorescence microscopy, Delta Vision, 60x; scale bar: 10 µm). (A) 
35 nm – glucosamine; (B) 35 nm – hydroxypropylamine; (C) 35 nm – taurine; (D) 
35 nm – PEG. (E) Cells exposed to various gold nanoparticles were analyzed for 
internalized gold nanoparticles by ICP-AES. Amounts of AuNPs were calculated per 
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cell. Results are shown as means ± SEM of four independent experiments each 
performed in triplicate (n = 4). *: P < 0.05, **: P > 0.01; ***: P < 0.001 (TWOway 
ANOVA with Tukey t-test). (F – I) Cells were exposed to AuNPs and analyzed by 
transmission electron microscopy (scale bar: 1.9 µm). Higher magnifications are 
shown in F’ – I’ (scale bar: 200 nm). (F) @glucosamine; (G) @hydroxypropylamine; 
(H) @taurine; (I) @PEG. 
 
Figure 2: Cytokine secretion of hCMEC/D3 after treatment with different gold 
nanoparticles. 
hCMEC/D3 were treated with 150 µg / mL AuNPs of different sizes and surface 
modifications. The concentrations of proinflammatory mediators ((A) IL-8, (B) MCP-
1, (C) sICAM, (D) sVCAM) were determined using ELISA after 24h, 48h and 72h. 
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TNFα treated cells were used as positive control. Untreated cells were used as 
control (Ctrl). The data represents the means ± SEM of two independent 
experiments each performed in triplicate (n = 2). *: P < 0.05, **: P > 0.01; ***: 
P < 0.001 (TWOway ANOVA with Dunnett t-test). 
 
Figure 3: Expression of tight junction proteins in hCMEC/D3 after treatment 
with different gold nanoparticles 
hCMEC/D3 were treated with 150 µg / mL gold nanoparticles of different sizes and 
surface modifications for 48 hours. The relative quantification of TJ proteins was 
determined using real-time PCR. Untreated cells have been used as control. The 
data represents the means ± SEM. of two independent experiments each performed 
in triplicate (n = 2). *: P < 0.05 (ONEway ANOVA with Dunnett t-test). 
 29 
 
 
Figure 4: Impact of AuNP treatment on the splicing of transcription factor 
XBP1 mRNA as an indication of UPR activation. 
hCMEC/D3 were treated with various AuNPs for 4 hours. Cells were analyzed for 
XBP1 mRNA splicing. (A) PCR was performed with XBP1 primers that amplify both 
variants of XBP1, unspliced (u) and spliced (s) variants. Cells treated with 10 µg / mL 
(i) or 150 µg / mL (ii) AuNPs were analyzed. Samples were plotted in the following 
order: glucosamine, hydroxypropylamine, taurine, PEG coated AuNPs. (A’) 
Tunicamycin was used as positive control for XBP1 splicing. (B) For the same 
samples (150 µg / mL) the amount of spliced XBP1 was quantified using real-time 
PCR. Untreated cells have been used as control. The data represents the means ± 
SEM of two independent experiments each performed in triplicate (n = 2). (TWOway 
ANOVA with Dunnett t-test). 
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Figure 5: Expression of UPR-related genes upon exposure to AuNPs. 
hCMEC/D3 were treated with various 150 µg / mL AuNPs for 4 and 24 hours. Real-
time PCR was used to quantify the expression of UPR related genes: (A) BiP, (B) 
Grp94, (C) ATF4, (D) PERK, (E) IRE1α, (F) ATF6. The data represents the means ± 
SEM of two independent experiments each performed in triplicate (n = 2). *: 
P < 0.05, **: P > 0.01 (TWOway ANOVA with Dunnett t-test). 
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Figure 6: Expression of CHOP in brain endothelial cells after AuNP treatment. 
hCMEC/D3 were treated with various 150 µg / mL AuNPs for various time points. 
The expression of CHOP was quantified by real-time PCR. Data are shown as 
relative quantification (RQ). Untreated control was set to 1. The data represents the 
means ± SEM of two independent experiments each performed in triplicate (n = 2). 
(TWOway ANOVA with Dunnett t-test). 
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Supplementary Material Figure 1: Cell viability of hCMEC/D3 after exposure to 
gold nanoparticles 
The endothelial cells hCMEC/D3 were exposed to different concentrations of gold 
nanoparticles (10, 50, 100, 250µg/ml) for 48 hours. Cell viability was measured by 
MTS assay. The cell viability of untreated cells (Ctrl) was set to 100%. Each column 
represents the mean ± standard deviation of three independent experiments; each of 
these was performed at least in triplicate (n ≥ 3; (TWOway ANOVA with Tukey t-
test)). 
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Supplementary Material Figure 2: Cytokine secretion of hCMEC/D3 after 
treatment with different gold nanoparticles. 
hCMEC/D3 were treated with 10 µg / mL gold nanoparticles of different sizes and 
surface modifications. The concentrations of pro-inflammatory mediators (IL-6, IL-8 
and MCP-1) were determined using ELISA after 24h. TNFα treated cells were used 
as positive control. Untreated cells were used as control (Ctrl). Each column 
represents the mean ± standard deviation. *: P < 0.05, ***: P < 0.001; (n ≥ 2; 
(TWOway ANOVA with Tukey t-test)). 
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Supplementary Material Figure 3: Impact of AuNP treatment on the splicing of 
transcription factor XBP1 mRNA. 
hCMEC/D3 were treated with various AuNPs (150 µg / mL) for 24 hours. Cells were 
analyzed for spliced XBP1 mRNA splicing using Real-time PCR (A), while RPL13A 
was detected as reference gene. Untreated control was set to 1. Each column 
represents the mean ± standard deviation (n = 2) (B) Cells were treated with 
Tunicamycin (Tu) as positive control for ER stress and XBP1 splicing for 24 hours. 
PCR was performed with XBP1 primers that amplify both variants of XBP1, 
unspliced (u) and spliced (s) variants. 
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Supplementary Material Figure 4: Expression of BiP upon exposure to AuNPs 
hCMEC/D3 were treated with various AuNPs (150 µg / mL) for 48 and 72 hours. 
Real-time PCR was used to quantify the expression of BiP. RPL13A was detected as 
reference gene. Data are shown as relative quantification (RQ). Untreated control 
was set to 1. Each column represents the mean ± standard deviation (n = 2). 
